Children’s Memorial Hermann Hospital and Cord Blood Registry are launching the first phase I safety study approved by the U.S. Food and Drug Administration on the use of cord blood stem cells to treat children with sensorineural hearing loss.
Click here for more info. (external link)
Posted January 31, 2012.